NCCN
text

US cancer network recommending expensive drugs based on weak evidence

GuidelinesforAmericanoncologistsoftenrecommendexpensiveandharmfulcancerdrugsforpatientsbasedon“weakevidence”,accordingtoanewstudyintheBritishMedicalJournal.TheB

Special Featured